• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    MEDIFAST INC filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    4/28/25 4:45:00 PM ET
    $MED
    Packaged Foods
    Consumer Staples
    Get the next $MED alert in real time by email
    med-20250428
    0000910329FALSE00009103292025-04-282025-04-280000910329exch:XNYS2025-04-282025-04-28

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    _____________________________________
    FORM 8-K
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of
    The Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported): April 28, 2025
    MEDIFAST, INC.
    (Exact name of registrant as specified in its charter)
    Delaware
    (State or other
    jurisdiction of incorporation)
    001-31573
    (Commission
    File Number)
    13-3714405
    (I.R.S. Employer
    Identification No.)
    100 International Drive, Baltimore, Maryland 21202
    (Address of Principal Executive Offices) (Zip Code)
    Registrant's telephone number, including area code: (410) 581-8042
    N/A
    (Former Name or Former Address, if Changed Since Last Report)
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each class
    Trading Symbol
    Name of each exchange on which registered
    Common Stock, par value $0.001 per share
    MED
    New York Stock Exchange
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
    Emerging growth company
    ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.o




    Item 2.02.    Results of Operations and Financial Condition.

    On April 28, 2025, Medifast, Inc. (the "Company") issued a press release announcing its earnings for the first quarter ended March 31, 2025.

    A copy of the press release is being furnished as Exhibit 99.1 attached hereto and is incorporated by reference herein. This information is being furnished in this report and shall not be deemed to be "filed" for any purpose, including for the purpose of Section 18 of the Securities and Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1993, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
    Item 9.01.    Financial Statements and Exhibits.
    (d)
    Exhibits.
    99.1
    Medifast Announces First Quarter 2025 Financial Results
    104.1Cover Page Interactive Data File (embedded within the Inline XBRL Document)



    Signature
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    MEDIFAST, INC.
    By:/s/ James P. Maloney
    James P. Maloney
    Chief Financial Officer
    Dated: April 28, 2025

    Get the next $MED alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $MED

    DatePrice TargetRatingAnalyst
    11/5/2024$16.50 → $17.00Underperform → Neutral
    DA Davidson
    6/5/2024$25.00 → $17.50Neutral → Underperform
    DA Davidson
    10/13/2023$82.00Equal-Weight
    Stephens
    11/4/2022$278.00 → $106.00Buy → Neutral
    DA Davidson
    8/4/2022$345.00 → $150.00Buy → Hold
    Jefferies
    2/24/2022$349.00 → $341.00Buy
    DA Davidson
    11/8/2021$395.00 → $349.00Buy
    DA Davidson
    More analyst ratings

    $MED
    SEC Filings

    See more
    • MEDIFAST INC filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - MEDIFAST INC (0000910329) (Filer)

      6/20/25 4:59:52 PM ET
      $MED
      Packaged Foods
      Consumer Staples
    • SEC Form DEF 14A filed by MEDIFAST INC

      DEF 14A - MEDIFAST INC (0000910329) (Filer)

      4/29/25 4:10:38 PM ET
      $MED
      Packaged Foods
      Consumer Staples
    • SEC Form DEFA14A filed by MEDIFAST INC

      DEFA14A - MEDIFAST INC (0000910329) (Filer)

      4/29/25 4:13:11 PM ET
      $MED
      Packaged Foods
      Consumer Staples

    $MED
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Medifast upgraded by DA Davidson with a new price target

      DA Davidson upgraded Medifast from Underperform to Neutral and set a new price target of $17.00 from $16.50 previously

      11/5/24 7:48:00 AM ET
      $MED
      Packaged Foods
      Consumer Staples
    • Medifast downgraded by DA Davidson with a new price target

      DA Davidson downgraded Medifast from Neutral to Underperform and set a new price target of $17.50 from $25.00 previously

      6/5/24 7:15:11 AM ET
      $MED
      Packaged Foods
      Consumer Staples
    • Stephens initiated coverage on Medifast with a new price target

      Stephens initiated coverage of Medifast with a rating of Equal-Weight and set a new price target of $82.00

      10/13/23 7:41:39 AM ET
      $MED
      Packaged Foods
      Consumer Staples

    $MED
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Xian Ming

      4 - MEDIFAST INC (0000910329) (Issuer)

      6/26/25 7:06:44 PM ET
      $MED
      Packaged Foods
      Consumer Staples
    • Director Schlackman Scott was granted 11,168 shares, increasing direct ownership by 78% to 25,549 units (SEC Form 4)

      4 - MEDIFAST INC (0000910329) (Issuer)

      6/26/25 7:05:00 PM ET
      $MED
      Packaged Foods
      Consumer Staples
    • Director Thomas Andrea B was granted 11,168 shares, increasing direct ownership by 87% to 24,017 units (SEC Form 4)

      4 - MEDIFAST INC (0000910329) (Issuer)

      6/26/25 7:04:28 PM ET
      $MED
      Packaged Foods
      Consumer Staples

    $MED
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chairman & CEO Chard Daniel R bought $5,003 worth of shares (381 units at $13.13) (SEC Form 4)

      4 - MEDIFAST INC (0000910329) (Issuer)

      6/17/25 6:20:00 PM ET
      $MED
      Packaged Foods
      Consumer Staples
    • Thomas Andrea B bought $3,471 worth of shares (50 units at $68.89), increasing direct ownership by 0.81% to 6,253 units (SEC Form 4)

      4 - MEDIFAST INC (0000910329) (Issuer)

      11/9/23 8:20:19 PM ET
      $MED
      Packaged Foods
      Consumer Staples
    • Hoer Michael A. bought $3,428 worth of shares (50 units at $68.89), increasing direct ownership by 0.60% to 8,375 units (SEC Form 4)

      4 - MEDIFAST INC (0000910329) (Issuer)

      11/9/23 8:20:03 PM ET
      $MED
      Packaged Foods
      Consumer Staples

    $MED
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Medifast Announces First Quarter 2025 Financial Results

      Medifast (NYSE:MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the first quarter ended March 31, 2025. First Quarter 2025 Revenue of $115.7 million, with revenue per active earning coach of $4,556 Independent active earning OPTAVIA coaches of 25,400 Net loss of $0.8 million, which includes an unrealized gain on investment in LifeMD (NASDAQ:LFMD) common stock of $0.4 million (net of tax) Loss per share of $0.07 Cash, Cash Equivalents, and Investment Securities of $164.6 million with no debt "In today's health and wellness landscape, more people than ever are seeking guidance not just for we

      4/28/25 4:05:00 PM ET
      $LFMD
      $MED
      Medical/Nursing Services
      Health Care
      Packaged Foods
      Consumer Staples
    • Medifast to Announce Financial Results for the First Quarter Ended March 31, 2025

      Medifast (NYSE:MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the quarter ended March 31, 2025 on Monday, April 28, 2025, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer. The conference call is scheduled to begin at 4:30 p.m. ET on April 28, 2025. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at www.MedifastInc.com or directly at https:

      4/14/25 4:05:00 PM ET
      $LFMD
      $MED
      Medical/Nursing Services
      Health Care
      Packaged Foods
      Consumer Staples
    • Medifast Announces Fourth Quarter and Full Year 2024 Financial Results

      Medifast (NYSE:MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Revenue of $119.0 million, with revenue per active earning coach of $4,391 Independent active earning OPTAVIA coaches of 27,100 Net income of $0.8 million (non-GAAP adjusted net income of $1.1 million) Earnings per diluted share ("EPS") of $0.07 (non-GAAP adjusted EPS of $0.10) Cash, Cash Equivalents, and Investment Securities of $162.3 million and no debt Full Year 2024 Revenue of $602.5 million Net income of $2.1 million (non-GAAP adjusted net i

      2/18/25 4:05:00 PM ET
      $LFMD
      $MED
      Medical/Nursing Services
      Health Care
      Packaged Foods
      Consumer Staples

    $MED
    Financials

    Live finance-specific insights

    See more
    • Medifast Announces First Quarter 2025 Financial Results

      Medifast (NYSE:MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the first quarter ended March 31, 2025. First Quarter 2025 Revenue of $115.7 million, with revenue per active earning coach of $4,556 Independent active earning OPTAVIA coaches of 25,400 Net loss of $0.8 million, which includes an unrealized gain on investment in LifeMD (NASDAQ:LFMD) common stock of $0.4 million (net of tax) Loss per share of $0.07 Cash, Cash Equivalents, and Investment Securities of $164.6 million with no debt "In today's health and wellness landscape, more people than ever are seeking guidance not just for we

      4/28/25 4:05:00 PM ET
      $LFMD
      $MED
      Medical/Nursing Services
      Health Care
      Packaged Foods
      Consumer Staples
    • Medifast to Announce Financial Results for the First Quarter Ended March 31, 2025

      Medifast (NYSE:MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the quarter ended March 31, 2025 on Monday, April 28, 2025, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer. The conference call is scheduled to begin at 4:30 p.m. ET on April 28, 2025. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at www.MedifastInc.com or directly at https:

      4/14/25 4:05:00 PM ET
      $LFMD
      $MED
      Medical/Nursing Services
      Health Care
      Packaged Foods
      Consumer Staples
    • Medifast Announces Fourth Quarter and Full Year 2024 Financial Results

      Medifast (NYSE:MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Revenue of $119.0 million, with revenue per active earning coach of $4,391 Independent active earning OPTAVIA coaches of 27,100 Net income of $0.8 million (non-GAAP adjusted net income of $1.1 million) Earnings per diluted share ("EPS") of $0.07 (non-GAAP adjusted EPS of $0.10) Cash, Cash Equivalents, and Investment Securities of $162.3 million and no debt Full Year 2024 Revenue of $602.5 million Net income of $2.1 million (non-GAAP adjusted net i

      2/18/25 4:05:00 PM ET
      $LFMD
      $MED
      Medical/Nursing Services
      Health Care
      Packaged Foods
      Consumer Staples

    $MED
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by MEDIFAST INC

      SC 13G/A - MEDIFAST INC (0000910329) (Subject)

      7/10/24 1:14:41 PM ET
      $MED
      Packaged Foods
      Consumer Staples
    • SEC Form SC 13G filed by MEDIFAST INC

      SC 13G - MEDIFAST INC (0000910329) (Subject)

      7/1/24 4:18:04 PM ET
      $MED
      Packaged Foods
      Consumer Staples
    • SEC Form SC 13G/A filed by MEDIFAST INC (Amendment)

      SC 13G/A - MEDIFAST INC (0000910329) (Subject)

      2/13/24 10:36:09 AM ET
      $MED
      Packaged Foods
      Consumer Staples

    $MED
    Leadership Updates

    Live Leadership Updates

    See more
    • KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

      NEW YORK, June 7, 2024 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, June 24, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P SmallCap 600 are more representative of the small-cap market space. The companies being removed from the S

      6/7/24 6:09:00 PM ET
      $ADTN
      $ALTR
      $ATNI
      $BMRN
      Telecommunications Equipment
      Utilities
      Computer Software: Prepackaged Software
      Technology
    • Medifast Appoints Steven Zenker as Vice President of Investor Relations

      BALTIMORE, March 2, 2023 /PRNewswire/ -- Medifast (NYSE:MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, today announced it has named Steven Zenker as Vice President of Investor Relations. Mr. Zenker has over 30 years of investor relations, financial planning and analysis, communications, and investment management experience. He reports to Chief Financial Officer Jim Maloney and will lead the strategy and continued implementation of the company's investor relations program. "We are pleased to welcome Steven to the Medifast t

      3/2/23 8:30:00 AM ET
      $MED
      Packaged Foods
      Consumer Staples